Endocrine Abstracts

Patients suffering from low-grade chronic inflammatory diseases such as rheumatoid arthritis, osteoarthritis, diabetes and obesity have low plasma SHBG levels. These diseases are characterized among other features by high plasma IL1β levels. The aim of the present study is to explore whether IL1β could regulate hepatic SHBG production to account for low SHBG levels in these diseases. We provide evidence that daily IL1β treatment reduces SHBG production in HepG2 ...

The reason why obesity (a chronic low-grade inflammatory disease) is associated with low levels of sex hormone-binding globulin (SHBG) remains to be elucidated. In the present study we provide evidence that TNFα (a proinflammatory cytokine that increases with obesity) reduces SHBG production by human HepG2 hepatoblastoma cells. The effect of TNFα on human SHBG expression was mediated by NF-κB which causes the downregulation of HNF4α: a key SHBG transcriptio...

Low plasma sex hormone-binding globulin (SHBG) levels are present in patients suffering chronic metabolic diseases, including non-alcoholic fatty liver disease (NAFLD). However, whether altered SHBG production plays a role in development and progression of this disease is unclear. To investigate SHBG involvement in NAFLD, we studied the effects of overexpressing SHBG in two mouse models, a genetically-induced model, by developing a double transgenic mouse by crossing the human...